GALT

Galectin Therapeutics

Price

chg

chg neg

quotes and stock data may be delayed 15 minutes

52 wk low

low api

52 wk hi

high api

Cash

$27.8M

Burn Rate (Qtr)

$6.3M

Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q1 '21

Drug Pipeline

Click on drug name or indication to see upcoming trial info, prior data, and more general information.

No drug found

We have found any drug for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Loading Catalysts...

search in progress

Pipeline powered by

GALT

BPIQ_Logo_RGB-01.jpg

Company Profile

Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function.

Recent Posts

See what the community is saying - click to see full post.